<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34158126</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>22</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice.</ArticleTitle><Pagination><StartPage>111</StartPage><MedlinePgn>111</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-021-01211-9</ELocationID><Abstract><AbstractText>The deposition of aggregated proteins is a common neuropathological denominator for neurodegenerative disorders. Experimental evidence suggests that disease propagation involves prion-like mechanisms that cause the spreading of template-directed aggregation of specific disease-associated proteins. In transgenic (Tg) mouse models of superoxide dismutase-1 (SOD1)-linked amyotrophic lateral sclerosis (ALS), inoculation of minute amounts of human SOD1 (hSOD1) aggregates into the spinal cord or peripheral nerves induces premature ALS-like disease and template-directed hSOD1 aggregation that spreads along the neuroaxis. This infectious nature of spreading pathogenic aggregates might have implications for the safety of laboratory and medical staff, recipients of donated blood or tissue, or possibly close relatives and caregivers. Here we investigate whether transmission of ALS-like disease is unique to the spinal cord and peripheral nerve inoculations or if hSOD1 aggregation might spread from the periphery into the central nervous system (CNS). We inoculated hSOD1 aggregate seeds into the peritoneal cavity, hindlimb skeletal muscle or spinal cord of adult Tg mice expressing mutant hSOD1. Although we used up to 8000 times higher dose-compared to the lowest dose transmitting disease in spinal cord inoculations-the peripheral inoculations did not transmit seeded aggregation to the CNS or premature ALS-like disease in hSOD1 Tg mice. Nor was any hSOD1 aggregation detected in the liver, kidney, skeletal muscle or sciatic nerve. To explore potential reasons for the lack of disease transmission, we examined the stability of hSOD1 aggregates and found them to be highly vulnerable to both proteases and detergent. Our findings suggest that exposed individuals and personnel handling samples from ALS patients are at low risk of any potential transmission of seeded hSOD1 aggregation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keskin</LastName><ForeName>Isil</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekhtiari Bidhendi</LastName><ForeName>Elaheh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe4;nnstr&#xf6;m</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Clinical Chemistry, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordstr&#xf6;m</LastName><ForeName>Ulrika</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-7757-2344</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Neurosciences, Ume&#xe5; University, 90185, Ume&#xe5;, Sweden. ulrika.nordstrom@umu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Aggregate stability</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Peripheral administration</Keyword><Keyword MajorTopicYN="N">Prion-like</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">Superoxide dismutase 1</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34158126</ArticleId><ArticleId IdType="pmc">PMC8220797</ArticleId><ArticleId IdType="doi">10.1186/s40478-021-01211-9</ArticleId><ArticleId IdType="pii">10.1186/s40478-021-01211-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol. 1991;30:686&#x2013;693. doi: 10.1002/ana.410300509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300509</ArticleId><ArticleId IdType="pubmed">1763893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J, Lelie H, Workman A, Prudencio M, Brown H, Fromholt S, Valentine J, Whitelegge J, Borchelt D. Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J Neurochem. 2014;128:305&#x2013;314. doi: 10.1111/jnc.12451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12451</ArticleId><ArticleId IdType="pmc">PMC3971632</ArticleId><ArticleId IdType="pubmed">24032979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Borchelt DR. Phenotypic diversity in ALS and the role of poly-conformational protein misfolding. Acta Neuropathol. 2020 doi: 10.1007/s00401-020-02222-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02222-x</ArticleId><ArticleId IdType="pmc">PMC7956917</ArticleId><ArticleId IdType="pubmed">32930869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, Borchelt DR. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt SE, O'Neal VM, Diamond JH, Borchelt DR. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103&#x2013;114. doi: 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, McMahon B, Gill S, Lelie HL, Fromholt S, Brown H, Valentine JS, Whitelegge JP, Borchelt DR. Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models. J Neurochem. 2017;140:140&#x2013;150. doi: 10.1111/jnc.13864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13864</ArticleId><ArticleId IdType="pmc">PMC5283795</ArticleId><ArticleId IdType="pubmed">27727458</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkler C, O'Neil AL, Slepian S, Qian F, Weinreb PH, Rubin LL. Aggregated SOD1 causes selective death of cultured human motor neurons. Sci Rep. 2018;8:16393. doi: 10.1038/s41598-018-34759-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34759-z</ArticleId><ArticleId IdType="pmc">PMC6219543</ArticleId><ArticleId IdType="pubmed">30401824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergemalm D, Forsberg K, Srivastava V, Graffmo KS, Andersen PM, Brannstrom T, Wingsle G, Marklund SL. Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. J Neurochem. 2010;114:408&#x2013;418. doi: 10.1111/j.1471-4159.2010.06753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06753.x</ArticleId><ArticleId IdType="pubmed">20412382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh J, Zetterstr&#xf6;m P, Andersen PM, Br&#xe4;nnstr&#xf6;m T, Graffmo KS, Jonsson PA, Lang L, Danielsson J, Oliveberg M, Marklund SL. Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc Natl Acad Sci U S A. 2015;112:4489&#x2013;4494. doi: 10.1073/pnas.1419228112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419228112</ArticleId><ArticleId IdType="pmc">PMC4394267</ArticleId><ArticleId IdType="pubmed">25802384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstrom P, Andersen PM, Marklund SL, Brannstrom T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest. 2016;126:2249&#x2013;2253. doi: 10.1172/JCI84360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P, et al. Identification of distinct pathological signatures induced by patient-derived alpha-synuclein structures in nonhuman primates. Sci Adv. 2020;6:eaaz9165. doi: 10.1126/sciadv.aaz9165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz9165</ArticleId><ArticleId IdType="pmc">PMC7220339</ArticleId><ArticleId IdType="pubmed">32426502</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197&#x2013;211. doi: 10.1016/s0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003;110:517&#x2013;536. doi: 10.1007/s00702-002-0808-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-002-0808-2</ArticleId><ArticleId IdType="pubmed">12721813</ArticleId></ArticleIdList></Reference><Reference><Citation>Breid S, Bernis ME, Babila JT, Garza MC, Wille H, Tamg&#xfc;ney G. Neuroinvasion of &#x3b1;-synuclein prionoids after intraperitoneal and intraglossal inoculation. J Virol. 2016;90:9182&#x2013;9193. doi: 10.1128/jvi.01399-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01399-16</ArticleId><ArticleId IdType="pmc">PMC5044858</ArticleId><ArticleId IdType="pubmed">27489279</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/s0896-6273(00)80272-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80272-x</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Burwinkel M, Lutzenberger M, Heppner FL, Schulz-Schaeffer W, Baier M. Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) Acta Neuropathol Commun. 2018;6:23. doi: 10.1186/s40478-018-0511-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0511-7</ArticleId><ArticleId IdType="pmc">PMC5836327</ArticleId><ArticleId IdType="pubmed">29506560</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot JM (1873) Lecons sur les maladies du syst&#xe8;me nervaux. 2nd series, collected by Bourneville. In: Charcot JM (1881) Lectures on the diseases of the nervous system, vol 2, series 2, Sigersen G (trans and ed). New Sydenham Society, London, pp 163&#x2013;204</Citation></Reference><Reference><Citation>Chia R, Tattum MH, Jones S, Collinge J, Fisher EM, Jackson GS. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e10627. doi: 10.1371/journal.pone.0010627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010627</ArticleId><ArticleId IdType="pmc">PMC2869360</ArticleId><ArticleId IdType="pubmed">20498711</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009;11:909&#x2013;913. doi: 10.1038/ncb1901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1901</ArticleId><ArticleId IdType="pmc">PMC2726961</ArticleId><ArticleId IdType="pubmed">19503072</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera F, Hench J, Lavenir I, Schweighauser G, Frank S, Goedert M, Tolnay M. Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol. 2014;127:299&#x2013;301. doi: 10.1007/s00401-013-1231-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1231-5</ArticleId><ArticleId IdType="pmc">PMC4253855</ArticleId><ArticleId IdType="pubmed">24362441</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisele YS, Oberm&#xfc;ller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M. Peripherally applied A&#x3b2;-containing inoculates induce cerebral &#x3b2;-amyloidosis. Science. 2010;330:980&#x2013;982. doi: 10.1126/science.1194516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194516</ArticleId><ArticleId IdType="pmc">PMC3233904</ArticleId><ArticleId IdType="pubmed">20966215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E, Bergh J, Zetterstr&#xf6;m P, Forsberg K, Pakkenberg B, Andersen PM, Marklund SL, Br&#xe4;nnstr&#xf6;m T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018 doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J Biol Chem. 1973;248:2645&#x2013;2649. doi: 10.1016/S0021-9258(19)44055-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)44055-6</ArticleId><ArticleId IdType="pubmed">4697386</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Br&#xe4;nnstr&#xf6;m T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, Pokrishevsky E, O'Neill MA, Gibbs E, Semenchenko V, Yousefi M, Wishart DS, Plotkin SS, et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O'Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805&#x2013;820. doi: 10.1007/s00401-014-1343-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1343-6</ArticleId><ArticleId IdType="pubmed">25296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Br&#xe4;nnstr&#xf6;m T, Gredal O, Nilsson P, Marklund SL. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73&#x2013;88. doi: 10.1093/brain/awh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Andersen PM, Marklund SL, Brannstrom T. Superoxide dismutase in amyotrophic lateral sclerosis patients homozygous for the D90A mutation. Neurobiol Dis. 2009;36:421&#x2013;424. doi: 10.1016/j.nbd.2009.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.006</ArticleId><ArticleId IdType="pubmed">19703565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC. Evidence for seeding of &#x3b2;-amyloid by intracerebral infusion of alzheimer brain extracts in &#x3b2;-amyloid precursor protein-transgenic mice. J Neurosci. 2000;20:3606&#x2013;3611. doi: 10.1523/jneurosci.20-10-03606.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.20-10-03606.2000</ArticleId><ArticleId IdType="pmc">PMC6772682</ArticleId><ArticleId IdType="pubmed">10804202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Takikawa M, Nakashima K, Hirano A, Cleveland DW, Kusaka H, Shibata N, Kato M, Nakano I, Ohama E. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:163&#x2013;184. doi: 10.1080/14660820050515160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515160</ArticleId><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H, Almer G, Yamashita S, Gu&#xe9;gan C, Nagai M, Xu Z, Sosunov AA, McKhann GM, Przedborski S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A. 2006;103:6025&#x2013;6030. doi: 10.1073/pnas.0509227103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509227103</ArticleId><ArticleId IdType="pmc">PMC1458691</ArticleId><ArticleId IdType="pubmed">16595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease. Neuron. 2019;103(627&#x2013;641):e627. doi: 10.1016/j.neuron.2019.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.035</ArticleId><ArticleId IdType="pmc">PMC6706297</ArticleId><ArticleId IdType="pubmed">31255487</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M. Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition. J Neurosci. 2011;31:14488&#x2013;14495. doi: 10.1523/JNEUROSCI.3088-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3088-11.2011</ArticleId><ArticleId IdType="pmc">PMC3229270</ArticleId><ArticleId IdType="pubmed">21994365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, So RWL, Lau HHC, Sang JC, Ruiz-Riquelme A, Fleck SC, Stuart E, Menon S, Visanji NP, Meisl G, et al. &#x3b1;-Synuclein strains target distinct brain regions and cell types. Nat Neurosci. 2020;23:21&#x2013;31. doi: 10.1038/s41593-019-0541-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0541-x</ArticleId><ArticleId IdType="pmc">PMC6930851</ArticleId><ArticleId IdType="pubmed">31792467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg MJ, Tibell L, Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc Natl Acad Sci U S A. 2002;99:16607&#x2013;16612. doi: 10.1073/pnas.262527099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.262527099</ArticleId><ArticleId IdType="pmc">PMC139191</ArticleId><ArticleId IdType="pubmed">12482932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohmann S, Bernis ME, Tachu BJ, Ziemski A, Grigoletto J, Tamguney G. Oral and intravenous transmission of alpha-synuclein fibrils to mice. Acta Neuropathol. 2019;138:515&#x2013;533. doi: 10.1007/s00401-019-02037-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02037-5</ArticleId><ArticleId IdType="pmc">PMC6778172</ArticleId><ArticleId IdType="pubmed">31230104</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk KC, Kehm VM, Zhang B, O&#x2019;Brien P, Trojanowski JQ, Lee VMY. Intracerebral inoculation of pathological &#x3b1;-synuclein initiates a rapidly progressive neurodegenerative &#x3b1;-synucleinopathy in mice. J Exp Med. 2012;209:975&#x2013;986. doi: 10.1084/jem.20112457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112457</ArticleId><ArticleId IdType="pmc">PMC3348112</ArticleId><ArticleId IdType="pubmed">22508839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons TJ, Gralla EB, Valentine JS. Biological chemistry of copper-zinc superoxide dismutase and its link to amyotrophic lateral sclerosis. Met Ions Biol Syst. 1999;36:125&#x2013;177. doi: 10.1201/9780203747605-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/9780203747605-5</ArticleId><ArticleId IdType="pubmed">10093924</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinowski DP, Fridovich I. Subunit association and side-chain reactivities of bovine erythrocyte superoxide dismutase in denaturing solvents. Biochemistry. 1979;18:5055&#x2013;5060. doi: 10.1021/bi00590a005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00590a005</ArticleId><ArticleId IdType="pubmed">115491</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund SL. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest. 1984;74:1398&#x2013;1403. doi: 10.1172/JCI111550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI111550</ArticleId><ArticleId IdType="pmc">PMC425307</ArticleId><ArticleId IdType="pubmed">6541229</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, et al. Exogenous induction of cerebral &#xdf;-amyloidogenesis is governed by agent and host. Science. 2006;313:1781&#x2013;1784. doi: 10.1126/science.1131864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1131864</ArticleId><ArticleId IdType="pubmed">16990547</ArticleId></ArticleIdList></Reference><Reference><Citation>Miake H, Mizusawa H, Iwatsubo T, Hasegawa M. Biochemical characterization of the core structure of alpha-synuclein filaments. J Biol Chem. 2002;277:19213&#x2013;19219. doi: 10.1074/jbc.M110551200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110551200</ArticleId><ArticleId IdType="pubmed">11893734</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougenot A-L, Nicot S, Bencsik A, Morignat E, Verch&#xe8;re J, Lakhdar L, Legastelois S, Baron T. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging. 2012;33:2225&#x2013;2228. doi: 10.1016/j.neurobiolaging.2011.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.06.022</ArticleId><ArticleId IdType="pubmed">21813214</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16:199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Hong RH, Mackenzie IR, Cashman NR. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS ONE. 2017;12:e0184384. doi: 10.1371/journal.pone.0184384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184384</ArticleId><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, Culotta VC, Borchelt DR. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet. 1999;8:1451&#x2013;1460. doi: 10.1093/hmg/8.8.1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.8.1451</ArticleId><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013;126:555&#x2013;573. doi: 10.1007/s00401-013-1160-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1160-3</ArticleId><ArticleId IdType="pmc">PMC3789892</ArticleId><ArticleId IdType="pubmed">23925565</ArticleId></ArticleIdList></Reference><Reference><Citation>Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC, Daugs ID, Kuo YM, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement. 2009;5:18&#x2013;29. doi: 10.1016/j.jalz.2008.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2008.10.004</ArticleId><ArticleId IdType="pmc">PMC2663406</ArticleId><ArticleId IdType="pubmed">19118806</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, et al. Intramuscular injection of &#x3b1;-synuclein induces CNS &#x3b1;-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci. 2014;111:10732&#x2013;10737. doi: 10.1073/pnas.1321785111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321785111</ArticleId><ArticleId IdType="pmc">PMC4115570</ArticleId><ArticleId IdType="pubmed">25002524</ArticleId></ArticleIdList></Reference><Reference><Citation>Senoo Y, Katoh K, Nakai Y, Hashimoto Y, Bando K, Teramoto S. Activity and stability of recombinant human superoxide dismutase in buffer solutions and hypothermic perfusates. Acta Med Okayama. 1988;42:169&#x2013;174. doi: 10.18926/AMO/31026.</Citation><ArticleIdList><ArticleId IdType="doi">10.18926/AMO/31026</ArticleId><ArticleId IdType="pubmed">3041738</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;hr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K. Purified and synthetic Alzheimer&#x2019;s amyloid beta (A&#x3b2;) prions. Proc Natl Acad Sci. 2012;109:11025&#x2013;11030. doi: 10.1073/pnas.1206555109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206555109</ArticleId><ArticleId IdType="pmc">PMC3390876</ArticleId><ArticleId IdType="pubmed">22711819</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarutani A, Arai T, Murayama S, Hisanaga SI, Hasegawa M. Potent prion-like behaviors of pathogenic alpha-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun. 2018;6:29. doi: 10.1186/s40478-018-0532-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0532-2</ArticleId><ArticleId IdType="pmc">PMC5907316</ArticleId><ArticleId IdType="pubmed">29669601</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB. Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients. Proc Natl Acad Sci U S A. 2014;111:10323&#x2013;10328. doi: 10.1073/pnas.1408900111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1408900111</ArticleId><ArticleId IdType="pmc">PMC4104857</ArticleId><ArticleId IdType="pubmed">24982139</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerman AL, Kazmi SA, Patel S, Freyman Y, Oehler A, Aoyagi A, Mordes DA, Halliday GM, Middleton LT, Gentleman SM, et al. MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol. 2018;135:49&#x2013;63. doi: 10.1007/s00401-017-1762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1762-2</ArticleId><ArticleId IdType="pmc">PMC5756500</ArticleId><ArticleId IdType="pubmed">28849371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>